| The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse MC Farrelly, JW Bray, GA Zarkin, BW Wendling Journal of health economics 20 (1), 51-68, 2001 | 164 | 2001 |
| The effects of prices and policies on the demand for marijuana: Evidence from the National Household Surveys on Drug Abuse MC Farrelly, JW Bray, G Zarkin, B Wendling, RL Pacula National Bureau of Economic Research, 1999 | 121 | 1999 |
| How vertical integration affects the quantity and cost of care for Medicare beneficiaries TG Koch, BW Wendling, NE Wilson Journal of health economics 52, 19-32, 2017 | 110 | 2017 |
| Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks TJ Hoerger, KE Downs, MC Lakshmanan, RC Lindrooth, LEO Plouffe Jr, ... Journal of Women's Health & Gender-Based Medicine 8 (8), 1077-1089, 1999 | 109 | 1999 |
| The role of education in the production of health: An empirical analysis of smoking behavior S Tenn, DA Herman, B Wendling Journal of health economics 29 (3), 404-417, 2010 | 54 | 2010 |
| Economics at the FTC: Hospital mergers, authorized generic drugs, and consumer credit markets J Farrell, DJ Balan, K Brand, BW Wendling Review of Industrial Organization 39, 271-296, 2011 | 52 | 2011 |
| Entry threats and pricing in the generic drug industry S Tenn, BW Wendling Review of Economics and Statistics 96 (2), 214-228, 2014 | 43 | 2014 |
| The effects of physician and hospital integration on medicare beneficiaries' health outcomes TG Koch, BW Wendling, NE Wilson Review of Economics and Statistics 103 (4), 725-739, 2021 | 34 | 2021 |
| Physician market structure, patient outcomes, and spending: an examination of Medicare beneficiaries T Koch, B Wendling, NE Wilson Health services research 53 (5), 3549-3568, 2018 | 32 | 2018 |
| Economics at the FTC: Drug and PBM mergers and drip pricing HA Shelanski, J Farrell, D Hanner, CJ Metcalf, MW Sullivan, BW Wendling Review of Industrial Organization 41, 303-319, 2012 | 26 | 2012 |
| A review of the economic literature on cross-market health care mergers K Brand, T Rosenbaum Antitrust LJ 82, 533, 2018 | 25 | 2018 |
| Informing the uninformed: How drug advertising affects check-up visits D Hosken, B Wendling International Journal of Industrial Organization 31 (2), 181-194, 2013 | 19 | 2013 |
| Estimating the causal effect of entry on generic drug prices using Hatch–Waxman exclusivity LM Olson, BW Wendling Review of Industrial Organization 53, 139-172, 2018 | 17 | 2018 |
| The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period LM Olson, BW Wendling Bureau of Economics, Federal Trade Commission, 2013 | 17 | 2013 |
| Economics at the FTC: Physician acquisitions, standard essential patents, and accuracy of credit reporting JA Carlson, LS Dafny, BA Freeborn, PM Ippolito, BW Wendling Review of Industrial Organization 43, 303-326, 2013 | 16 | 2013 |
| Estimating the effect of entry on generic drug prices using Hatch-Waxman exclusivity L Olson, BW Wendling Federal Trade Commission, Bureau of Economics, Working Paper, 2013 | 6 | 2013 |
| The effect of generic drug competition on generic drug prices during the hatch-waxman 180-day exclusivity period. Washington, DC: Bureau of Economics Federal Trade Commission LM Olson, BW Wendling | 3 | 2013 |
| Entry Threats and Pricing in the Generic Drug Industry B Wendling, S Tenn Bureau of Economics, Federal Trade Commission, 2010 | 3 | 2010 |
| The Importance of Substitution in Assessing Health Care Provider Mergers BW Wendling, NE Wilson The Antitrust Bulletin 59 (3), 515-525, 2014 | 2 | 2014 |
| Physician Market Concentration and Patient Welfare: An Examination of Medicare Beneficiaries T Koch, BW Wendling, NE Wilson Health Services Research 53, 3549-3568, 2018 | 1 | 2018 |
Nathan WilsonCompass Lexecon在 compasslexecon.com 的电子邮件经过验证
